Fig. 5From: N6-methyladenosine (m6A) RNA methylation regulator SNRPC is a prognostic biomarker and is correlated with immunotherapy in hepatocellular carcinomaA Abundance of TME cells between the high- and low-SNRPC groups calculated by MCP-counter. B Box plot showing the proportion of TME cells between the high- and low-SNRPC groups analyzed by MCP-counter. C, D Heat map and box plot showing the infiltration of immune cells between the high- and low-SNRPC groups calculated by ssGSEABack to article page